Lv4
546 积分 2022-09-16 加入
Chronic Myeloid Leukemia
10天前
已完结
BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?
12天前
已完结
Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis
24天前
已完结
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors
3个月前
已关闭
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease
3个月前
已完结
Graves disease: latest understanding of pathogenesis and treatment options
3个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
4个月前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
4个月前
已完结
A shifting market environment and strategies fueling innovation in prostate cancer treatment
4个月前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
5个月前
已完结
皖公网安备34019202002308
